Detalles de la búsqueda
1.
Postdischarge Noninvasive Telemonitoring and Nurse Telephone Coaching Improve Outcomes in Heart Failure Patients With High Burden of Comorbidity.
J Card Fail
; 29(5): 774-783, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36521727
2.
Patient-reported Outcomes After External Beam Radiotherapy With Low Dose Rate Brachytherapy Boost vs Radical Prostatectomy for Localized Prostate Cancer: Five-year Results From a Prospective Comparative Effectiveness Study.
J Urol
; 208(6): 1226-1239, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36006050
3.
Association between Treatment for Localized Prostate Cancer and Mental Health Outcomes.
J Urol
; 207(5): 1029-1037, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34978488
4.
Five-year outcomes from a prospective comparative effectiveness study evaluating external-beam radiotherapy with or without low-dose-rate brachytherapy boost for localized prostate cancer.
Cancer
; 127(11): 1912-1925, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33595853
5.
Patient-Reported Financial Toxicity Associated with Contemporary Treatment for Localized Prostate Cancer.
J Urol
; 205(3): 761-768, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33252300
6.
Assessing the Quality of Surgical Care for Clinically Localized Prostate Cancer: Results from the CEASAR Study.
J Urol
; 204(6): 1236-1241, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32568605
7.
Patient-Reported Outcomes Through 5 Years for Active Surveillance, Surgery, Brachytherapy, or External Beam Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer.
JAMA
; 323(2): 149-163, 2020 01 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-31935027
8.
Interpretation of Domain Scores on the EPIC-How Does the Domain Score Translate into Functional Outcomes?
J Urol
; 202(6): 1150-1158, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31216252
9.
The Effect of Nerve Sparing Status on Sexual and Urinary Function: 3-Year Results from the CEASAR Study.
J Urol
; 199(5): 1202-1209, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29253578
10.
Validating the total illness burden index for prostate cancer (TIBI-CaP) in men with castration-resistant prostate cancer: data from TRUMPET.
Future Oncol
; 14(6): 527-536, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29417827
11.
12.
Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years.
JAMA
; 317(11): 1126-1140, 2017 03 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-28324093
13.
The Comparative Harms of Open and Robotic Prostatectomy in Population Based Samples.
J Urol
; 195(2): 321-9, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26343985
14.
Impact of Adherence to Quality Measures for Localized Prostate Cancer on Patient-reported Health-related Quality of Life Outcomes, Patient Satisfaction, and Treatment-related Complications.
Med Care
; 54(8): 738-44, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27219634
15.
Predicting the Risk of Breakthrough Urinary Tract Infections: Primary Vesicoureteral Reflux.
J Urol
; 194(5): 1396-401, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26066405
16.
Perioperative goal-directed therapy and postoperative outcomes in patients undergoing high-risk abdominal surgery: a historical-prospective, comparative effectiveness study.
Crit Care
; 19: 261, 2015 Jun 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-26088649
17.
Mental health symptoms and patient-reported diabetes symptom burden: implications for medication regimen changes.
Fam Pract
; 32(3): 317-22, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25846216
18.
Contemporary prevalence of pretreatment urinary, sexual, hormonal, and bowel dysfunction: Defining the population at risk for harms of prostate cancer treatment.
Cancer
; 120(8): 1263-71, 2014 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24510400
19.
A framework for crafting clinical practice guidelines that are relevant to the care and management of people with multimorbidity.
J Gen Intern Med
; 29(4): 670-9, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24442332
20.
Matching tumor risk with aggressiveness of treatment in men with multiple comorbidities and early-stage prostate cancer.
Cancer
; 119(19): 3446-53, 2013 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23861016